Serum C‑Reactive Protein (CRP) Titres in Bipolar Disorder: Systematic Review | ||
| Benha Medical Journal | ||
| Articles in Press, Accepted Manuscript, Available Online from 01 November 2025 PDF (733.48 K) | ||
| Document Type: Review Article | ||
| DOI: 10.21608/bmfj.2025.410428.2595 | ||
| Authors | ||
| Marwa F. Ebrahim1; Victor S. Mikhael2; Mohamed M. El-Hamady3; Mohammed R. El-feky4; Emad M. Gebriel* 5 | ||
| 1Lecturer of psychiatry Faculty of Medicine, Benha University | ||
| 2Professor of Psychiatry Faculty of Medicine, Benha University | ||
| 3Professor of Psychiatry Faculty of Medicine - Benha University | ||
| 4Professor of Psychiatry Military Medical Academy | ||
| 5M.Sc. Degree in Neuropsychiatry Medicine | ||
| Abstract | ||
| Bipolar disorder (BD) is a severe psychiatric illness linked to chronic inflammation, with elevated C-reactive protein (CRP) levels frequently reported, although findings across studies remain inconsistent. This systematic review synthesized evidence from 18 eligible studies, identified through a comprehensive search of Scopus, PubMed, and Web of Science (2010–2025), to evaluate CRP as a potential biomarker in BD and to explore its associations with disease phases, comorbidities, and other psychiatric disorders. The included cross-sectional, case-control, and cohort studies measured CRP in BD populations compared with healthy or psychiatric controls. Overall, CRP titres were consistently higher in BD than in healthy controls, with some studies indicating peak elevations during manic episodes. Comparisons with schizophrenia and depression yielded mixed findings, suggesting that inflammation may not be specific to BD. Methodological heterogeneity, inconsistent adjustment for confounding factors such as metabolic comorbidities and medication use, and a predominance of cross-sectional designs limited interpretability. Notably, only one large cohort study linked elevated CRP levels to subsequent BD onset, pointing to possible predictive value. These findings support the role of CRP in BD pathophysiology, yet its diagnostic or prognostic utility remains uncertain. Further longitudinal research using standardized methodologies is needed, and therapeutic strategies targeting inflammation may hold promise if confounding influences are adequately addressed. | ||
| Keywords | ||
| C - reactive protein; Bipolar Disorder; Schizophrenia | ||
|
Statistics Article View: 3 PDF Download: 1 |
||
